Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.

Detalles Bibliográficos
Autores principales:	Jarius, S, Jacob, S, Waters, P, Jacob, A, Littleton, E, Vincent, A
Formato:	Journal article
Lenguaje:	English
Publicado:	2008

Ejemplares similares

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
por: Waters, P, et al.
Publicado: (2008)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
por: Paul, F, et al.
Publicado: (2007)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
por: Jarius, S, et al.
Publicado: (2008)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
por: Friedemann Paul, et al.
Publicado: (2007-04-01)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
por: Jarius, S, et al.
Publicado: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
por: Jarius, S, et al.
Publicado: (2008)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
por: Akman-Demir, G, et al.
Publicado: (2011)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
por: Kitley, J, et al.
Publicado: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
por: Kitley, J, et al.
Publicado: (2013)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
por: Waters, P, et al.
Publicado: (2008)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Waters, P, et al.
Publicado: (2015)

Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
por: Simone Mader, et al.
Publicado: (2010-01-01)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
por: Min, J, et al.
Publicado: (2010)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, P, et al.
Publicado: (2016)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
por: Kitley, J, et al.
Publicado: (2012)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
por: Leite, M, et al.
Publicado: (2009)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
por: Cavus, F, et al.
Publicado: (2013)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
por: Kitley, J, et al.
Publicado: (2014)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
por: Kim, S, et al.
Publicado: (2013)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
por: Kitley, J, et al.
Publicado: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
por: Kitley, J, et al.
Publicado: (2013)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Kerr Douglas, et al.
Publicado: (2008-05-01)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
por: Palace, J, et al.
Publicado: (2010)

The distribution characteristics of aquaporin 4 antibody in patients with neuromyelitis optica and the relationship between aquaporin 4 antibody and oligoclonal bands
por: Hui-cong NIU, et al.
Publicado: (2014-09-01)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
por: Romain Marignier, et al.
Publicado: (2010-09-01)

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
por: Jarius Sven, et al.
Publicado: (2010-09-01)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
por: Kitley, J, et al.
Publicado: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
por: Kitley, J, et al.
Publicado: (2014)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
por: Cheng, F, et al.
Publicado: (2014)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
por: Wilson, R, et al.
Publicado: (2018)

The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders
por: Sato, D, et al.
Publicado: (2013)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
por: Nour, M, et al.
Publicado: (2015)

Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica
por: Jacobson, L, et al.
Publicado: (2008)

NMO-IgG in the diagnosis of neuromyelitis optica.
por: Jarius, S, et al.
Publicado: (2007)

Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.
por: Patricia A Nelson, et al.
Publicado: (2010-11-01)

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity
por: Jeffrey L. Bennett, et al.
Publicado: (2024-10-01)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
por: Kitley, J, et al.
Publicado: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
por: Kitley, J, et al.
Publicado: (2012)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
por: Jarius, S, et al.
Publicado: (2007)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
por: Pittock, S, et al.
Publicado: (2019)